BetterLife Pharma Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BETRF | MNOV | TELO | GOSS | NMRA | GLSI | |
|---|---|---|---|---|---|---|
| Market cap | 98.26M | 69.89M | 77.30M | 53.64M | 89.03M | 213.57M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -2.8 | -3.7 | -0.6 | -0.7 | -17.7 |
| Price/book | -3.4 | 1.9 | 14.4 | -0.6 | 2.0 | 68.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +238.30% | +17.36% | −36.75% | −94.93% | −73.81% | +56.79% |
| Today | −2.45% | −2.07% | −0.92% | −1.35% | +10.96% | −5.03% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BETRF news ›BetterLife Pharma Establishes Scientific Advisory Board for Headache Program; Professor Peter Goadsby Appointed Co-Chair
Brain Prize co-recipient whose research identified CGRP as a central driver of migraine joins to guide development of BETR-001 in chronic cluster headache and chronic migraine The SAB will advise the Company's management and Board of…
BetterLife Pharma faces legal claim from director over convertible debenture dispute.
BetterLife Pharma announced a legal claim filed by independent director Steven Sangha in British Columbia's Supreme Court regarding repayment of a convertible debenture issued in June 2026. Sangha seeks conversion of the debenture into…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
stocktitan.net2
-
newsfilecorp.com1
-
pluang.com1
-
theglobeandmail.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.